Latest Updates
July 2005 Combination Trial Updates and Additions

Protocol ID	Trial Title
	A Phase I Dose Escalation Trial of Targretin and Ontak in Patients with Hematologic Malignancies
NH-0139, NCI-V01-1681	Phase II Study of Docetaxel, Estramustine, and Thalidomide in Patients with Hormone-Refractory Prostate Cancer
CWRU-1301; NCI-5389; CWRU-050212	Phase I Study of Erlotinib, Docetaxel, and Radiotherapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
JHOC-J0220, JHOC-02072506, NCI-5869, CDR0000301882	A Phase I Clinical Trial of Erlotinib, Fluorouracil, Leucovorin Calcium, and Oxaliplatin (FOLFOX-4) in Patients with Metastatic or Locally Advanced Colorectal Cancer
MSKCC-03031; NCI-5441	A Phase I Clinical Trial of Erlotinib, Gemcitabine, and Radiotherapy in Patients with Locally Advanced Unresectable Pancreatic Cancer
CTRC-IDD-0135; NCI-5439	Phase I Study of Erlotinib, Trastuzumab (Herceptin), and Paclitaxel in Patients with Advanced Solid Tumors
OSU-02H0084; OSU-0213; NCI-5393	Phase I/II Study of Erlotinib and Docetaxel in Patients with Locally Advanced, Metastatic, or Recurrent Squamous Cell Carcinoma of the Head and Neck
NCCTG-N0177	A Dose-Escalation, Phase I/II Clinical Trial of Erlotinib and Radiotherapy in Patients with Glioblastoma Multiforme
NYU-0230, NCI-5886, NYU-1102-590, NYWCCC-NYU-0230	Phase I/II Study of Erlotinib, Carboplatin, and Paclitaxel in Patients with Stage III or IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Carcinoma
NCCTG-N0234	Phase II Study of Erlotinib and Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and/or Taxane
UCLA-0106020, GENENTECH-OSI2365s, NCI-G02-2057	Phase I/II Study of Trastuzumab (Herceptin) and Erlotinib as First-Line Therapy in Women with Metastatic Breast Cancer Associated with HER-2/neu Overexpression
NCI-03-C-0085	Phase III randomized study of operative debulking and systemic chemotherapy with or without intra- and peri-operative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from low-grade gastrointestinal adenocarcinoma
FRE-GERCOR-GEM-GEMOX/D00-3, EU-20324	Phase III randomized study of gemcitabine with or without oxaliplatin in patients with locally advanced or metastatic unresectable pancreatic adenocarcinoma
MSKCC-03078, LILLY-H3E-US-JMGA, CDR0000339681	Phase II Clinical Trial of Neoadjuvant Pemetrexed and Cisplatin Followed by Extrapleural Pneumonectomy and Radiotherapy in Patients with Stage I, II, or III Pleural Mesothelioma
5141	A Phase II Clinical Trial of Pemetrexed Combined with Gemcitabine in Metastatic Breast Cancer Patients After Taxane Therapy
7221	A Phase I/II Clinical Trial of Biweekly Pemetrexed and Gemcitabine in Patients with Advanced Cancer
7213	Pemetrexed Combined with Gemcitabine for Chemotherapy-Naive Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
7214	Pemetrexed Combined with Gemcitabine for Patients with Malignant Pleural or Peritoneal Mesothelioma Who Have Not Had Previous Chemotherapy
NCCTG-N014A	Phase II Study of Oxaliplatin, Fluorouracil, Leucovorin Calcium, and Cetuximab in Patients with Unresectable Hepatic Metastases Secondary to Metastatic Colorectal Adenocarcinoma
ECOG-E8200	Phase II Randomized Study of Irinotecan and Docetaxel with or Without Cetuximab in Patients with Metastatic Adenocarcinoma of the Pancreas
EORTC-21011	A randomized, open-label, multicenter, phase III clinical trial of ultraviolet A light therapy with methoxsalen with or without bexaretene in patients with mycosis fungoides
UCLA-0306083, CDR0000335434	A Phase I Clinical Trial of Celecoxib and Erlotinib in Patients with Stage IIIb or IV Non-Small Cell Lung Cancer
LIGAND-L1069-49 (SPIRIT I)	Randomized Phase III Trial Comparing Targretin Capsules, Cisplatin and Vinorelbine Against Cisplatin and Vinorelbine in Chemotherapy-Naive Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
LIGAND-L1069-48, BMC-C-7093-49, UCLA-0301086 (SPIRIT II)	A Randomized Phase III Clinical Trial of Carboplatin and Paclitaxel with Bexarotene Versus Carboplatin and Paclitaxel Alone in Patients with Chemotherapy-Naive Stage IIIB or IV Non-Small Cell Lung Cancer
DFCI-03083, SPORE trial	Phase II Randomized Trial of Low-Dose Cyclophosphamide and Methotrexate with or Without Bevacizumab in Women with Metastatic Breast Cancer
2003-0520	A Non-Randomized, Open Label, Active Control, Phase II Clinical Trial (protocol ID: 2003-0520) of Bevacizumab and Rituximab in Patients with Relapsed and Chemotherapy or Rituxan-Refractory Aggressive B-cell Non-Hodgkin’s Lymphoma
CA225014, BMS-014, EXPLORE • FOLFOX-4	A Randomized Phase III Clinical Trial of Cetuximab in Combination with 5-Fluorouracil (5-FU)/Leucovorin/Oxaliplatin (FOLFOX-4) as a Second Line Treatment in Patients with Metastatic, EGFr-positive Colorectal Cancer
EORTC-10021, IDBBC-10021	A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial pf Anastrozole Monotherapy or in Combination with Gefitinib in Postmenopausal Women with Metastatic or Locally Recurrent Breast Cancer
ECOG-4101	A Randomized, Open-Label, Phase II Clinical Trial of Anastrozol and Gefitinib Compared to Fulvestrant and Gefitinib in Postmenopausal Women with Recurrent or Metastatic Hormone Receptor-Positive Breast Cancer
ZD1839US/0713, NCT00077025	A Randomized, Double-Blind, Placebo Controlled, Phase II Clinical Trial of Anastrozole with Placebo Compared to Anastrozole with Gefitinib in Postmenopausal Patients with Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer
DMS-0236, ZENECA-IRUSIRES0162	A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial of Gefitinib with or Without Tamoxifen in Patients with Tamoxifen-Resistant Metastatic Breast Cancer
VICC-BRE-0249	A Randomized Phase II Pilot Clinical Trial of Gefitinib Followed By Local Surgery in Women with Ductal Carcinoma In Situ of the Breast
ZD1839IL/0225, NCT00069290	A Phase II Clinical Trial of Tamoxifen (20 Mg) and Gefitinib (250 Mg) Compared to Tamoxifen (20 Mg) and Placebo in Patients with Estrogen Receptor and/or Progesterone Positive Metastatic Breast Cancer
NCI-04-C-0141, NCI-5926	A Pilot, Dose-Escalation, Phase I Clinical Trial of Gefitinib, Paclitaxel, and Radiotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
CDR0000370806, SWOG-S0342	A Randomized Phase II Clinical Trial of Concurrent Versus Sequential Paclitaxel, Carboplatin and Cetuximab in Patients with Stage IIIb or IV Non-Small Cell Lung Cancer
CDR0000365614, MSKCC-04006	A Non-Randomized, Open-Label, Pilot, Phase II Clinical Trial of Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Patients with Locally Advanced or Locally Recurrent Rectal Cancer
CDR0000360850, RTOG-0234	A Randomized Phase II Clinical Trial of Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Patients with Resected Stage III or IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
GOG-0146P, BMS-CA225-019	A Phase II Clinical Trial of Cetuximab and Carboplatin in Patients with Recurrent, Platinum-Sensitive, Ovarian Epithelial or Primary Peritoneal Cancer
MSKCC-04021, NCI-6447	A Non-Randomized, Open-Label, Phase II Clinical Trial of Bevacizumab, Irinotecan and Cisplatin in Patients with Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
CWRU-3100, NCI-2722, CDR0000069090	A Phase II Clinical Trial of Neoadjuvant Docetaxel with or Without Bevacizumab in Patients with Locally Unresectable, Advanced Breast Cancer
DFCI-02025, NCI-5642	A Phase I Clinical Trial of Neoadjuvant Bevacizumab, 5-Fluououracil, and Radiation Therapy Followed by Surgery in Patients with Primary and Non-Metastatic Rectal Cancer
ICCG-C/14/96; EU-20040	Phase III Trial of Adjuvant Epirubicin with or Without Docetaxel and Concurrent or Sequential Tamoxifen in Postmenopausal Women with Node-Positive Breast Cancer
SWS-SAKK-43/99; EU-99042	Phase III Randomized Trial of Preoperative Compared to Postoperative Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in Patients with Locally Advanced Operable Gastric Carcinoma
ID01-580, NCT00050167	Phase III Trial Evaluating the Differing Taxanes/Taxane Combinations on the Outcomes of Patients with Operable Breast Cancer
CWRU-LILY-1503; LILLY-B9E-US-S245	Phase III Randomized Trial of Gemcitabine and Carboplatin Followed By Immediate Docetaxel Compared with Delayed Docetaxel in Patients with Stage IIIB or IV Non-Small Cell Lung Cancer
UCLA-9911084; AVENTIS-GIA-11156; GENENTECH-H2269s	Phase III Randomized Trial of Neoadjuvant Docetaxel and Carboplatin with or Without Trastuzumab (Herceptin) in Women with Locally Advanced Breast Cancer
FRE-FNCLCC-GETUG-12/0203; EU-20238	Phase III Randomized Trial of Neoadjuvant Releasing Factor Agonist Therapy and Antiandrogen Therapy with or Without Docetaxel And Estramustine in Patients with Locally Advanced Prostate Cancer or with A High Risk of Relapse
SWOG-S0205, CDR0000347414	A Phase III Randomized Clinical Trial of Gemcitabine with and Without Cetuximab as First-Line Therapy in Patients with Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
EORTC-10994; ACCOG-EORTC-10994; SAKK-EORTC-10994; SBGC-EORTC-10994	Phase III Randomized Trial of Neoadjuvant Fluorouracil, Epirubicin, and Cyclophosphamide Versus Neoadjuvant Docetaxel and Epirubicin Followed By Radiotherapy and Surgery in Women with Locally Advanced, Inflammatory, or Large Operable Breast Cancer
LMU-ADEBAR; EU-20221	Phase III Randomized Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Versus Docetaxel, Epirubicin, and Cyclophosphamide in Women with Primary Breast Cancer
Dox-2a-07; NCT00082472	Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients with Non-Small-Cell Lung Carcinoma (NSCLC)
CHNMC-03049; ZENECA-1839US/0274; ZENECA-IRUSIRES0012	Phase I/II Trial of Gefitinib, Trastuzumab (Herceptin), and Docetaxel in Patients with HER2/neu-Overexpressing Metastatic Adenocarcinoma of the Breast
2938	A Phase III Clinical Trial of Pemetrexed and Cisplatin Compared to Gemcitabine and Cisplatin in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
7216	A Phase II Clinical Trial of Pemetrexed and Cisplatin Followed by Surgery and Radiation in Patients with Pleural Mesothelioma
UCLA-0308082; AVENTIS-GIA-16115; GENENTECH-OSI-2527S	Phase II Trial of Docetaxel and Erlotinib in Older Patients with Progressive Hormone Refractory Prostate Cancer
NCI-04-C-0132	Phase II Trial of Docetaxel, Estramustine, and Thalidomide in Patients with Androgen-Independent Metastatic Adenocarcinoma of the Prostate
MSKCC-03076	Phase II Trial of Rapid Hormonal Cycling with Testosterone and Leuprolide in Combination with Docetaxel in Patients with Recurrent or Non-Castrate Metastatic Adenocarcinoma of the Prostate
FCCC-03003	Phase II Randomized Trial of Bevacizumab with or Without Docetaxel in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma
ID02-668; NCT00076310	A Nonrandomized, Open Label, Uncontrolled, Single Group Assignment, Phase II Clinical Trial of Erlotinib, Cisplatin and Docetaxel in Patients with Head and Neck Squamous Cell Cancer
SWOG-S0215	Phase II Pilot Trial of Trastuzumab (Herceptin), Docetaxel, and Vinorelbine with Filgrastim (G-CSF) Support in Women with HER2-Positive Stage IV Breast Cancer
MSKCC-04003	Phase I Trial of Gefitinib and Docetaxel in Patients with Advanced Solid Tumors
NCCTG-N0432	Phase II Trial of Docetaxel, Capecitabine, and Bevacizumab as First-Line Chemotherapy in Patients with Metastatic Breast Cancer
NCI-02-C-0149	Phase I Trial of Ketoconazole and Docetaxel in Patients with Metastatic Androgen-Independent Prostate Cancer
UCCRC-11432B, NCI-5411, CDR0000069474	Phase I Trial of Erlotinib and Radiotherapy Plus Either Cisplatin, Etoposide, and Docetaxel or Carboplatin and Paclitaxel in Patients with Inoperable Stage III Non-Small Cell Lung Cancer
RPCI-RPC-0207, ZENECA-1839US/0295	A Dose-Escalation, Phase I Clinical Trial of Calcitriol and Gefitinib with or without Dexamethasone in Patients with Advanced Solid Tumors
ECOG-E1302, CTSU	A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase III Clinical Trial of Docetaxel with or without Gefitinib in Patients with Metastatic or Locally Recurrent Squamous Cell Carcinoma of the Head and Neck
RPCI-I-17403, ZENECA-IRUSIRES0414	A Phase I/II Clinical Trial of Capecitabine, Oxaliplatin, and Gefitinib in Patients with Metastatic Colorectal Cancer
MSKCC-04010	A Phase I/II Clinical Trial of Everolimus and Gefitinib in Patients with Progressive Glioblastoma Multiforme or Progressive Castrate Metastatic Prostate Cancer
DUMC-4939-03-6R0, VAMC-DURHAM-00813, DUMC-4939-04-6R1	An Open-Label, Dose-Escalation, Phase I Clinical Trial of Celecoxib and Gefitinib in Patients who are Former Smokers with Stage IIIb Or IV, Recurrent or Progressive Non-Small Cell Lung Cancer
ID99-146	A Phase III Clinical Trial of Neoadjuvant Therapy with Paclitaxel and Anthracycline-Containing Chemotherapy [Fluorouracil, Epirubicin, and Cyclophosphamide (FEC)] with or Without Trastuzumab in Patients with HEr2 Positive Breast Cancer
CALGB-80303 (CTSU)	A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial of Gemcitabine Alone and in Combination with Bevacizumab in Patients with Locally Advanced or Metastatic Adenocarcinoma of the Pancreas
040257, 04-C-0257, NCI-04-C-0257	A Phase II Clinical Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Previously Untreated Patients with Androgen-Independent Prostate Cancer
ML17771, NCT00087620	An Open-Label, Randomized Phase III Trial of Capecitabine In Combination with Docetaxel or Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer.
CDR0000069196; SWS-SAKK-16/00; EU-20138, NCT00030771	Phase III Trial of Neoadjuvant Docetaxel and Cisplatin with or Without Radiotherapy in Patients with Non-Small Cell Lung Cancer and Mediastinal Lymph Node Metastases
CDR0000068897; MDA-ID-00156; NCI-3410, NCT00024167	Randomized Phase III Trial to Compare the Effectiveness of Chemotherapy with or Without Strontium-89 in Treating Patients Who Have Prostate Cancer That Has Spread to the Bone.
ECOG-E2303	A Phase II Clinical Trial of Neoadjuvant Induction Therapy Comprising of Cetuximab, Paclitaxel, and Carboplatin Followed by Chemoradiotherapy Comprising of Cetuximab, Paclitaxel, Carboplatin, and Radiotherapy in Patients with Stage III or IV Operable Squamous Cell Cancer of the Head and Neck
CAN-NCIC-PR7, CAN-NCIC-JPR7, SWOG-JPR7	Phase III Randomized Trial of Intermittent Compared to Continuous Androgen Suppression in Patients with Prostate-Specific Antigen Progression in the Clinical Absence of Distant Metastases After Prior Radiotherapy for Prostate Cancer
CAN-NCIC-PR3, EU-99013, ISRCTN24991896, NCI-T94-0110O, CALGB-9593, ECOG-JPR03, MRC-PR07, SWOG-JPR3	Phase III Randomized Trial of Total Androgen Blockade with or Without Pelvic Irradiation in Patients with Locally Advanced Adenocarcinoma of the Prostate
MDA-2003-0922, NCI-6459	Phase II Randomized Trial of Hormonal Ablative Therapy, Doxorubicin, and Zoledronate with or Without Strontium Chloride Sr 89 in Patients with Androgen-Dependent Prostate Cancer and Bone Metastases
BC-PR-6	Phase II Trial of Antineoplastons A10 and AS2-1 Capsules with Total Androgen Blockade in Patients with Stage III or IV Adenocarcinoma of the Prostate
CALGB-99809	Phase II Trial of Androgen-Suppression Therapy Combined with External-Beam Radiotherapy and Boost Brachytherapy in Patients with Intermediate-Risk Localized Prostate Cancer
CALGB-99811	Phase II Trial of Neoadjuvant Paclitaxel, Estramustine, Carboplatin, and Androgen Ablation Followed By Radiotherapy in Patients with Poor-Prognosis Locally Advanced Prostate Cancer
00-5891, NCT00041470	Phase I/II Trial of Navelbine (Vinorelbine), Taxol (Paclitaxel), Herceptin (Trastuzumab) and Neupogen (Filgrastim) in Stage IV Breast Cancer
UNC-LCCC-0310, UNC-GCRC-2102-ORC	Phase II Trial of Multiepitope Autologous Dendritic Cell Vaccine, Trastuzumab, and Vinorelbine in Women with Locally Recurrent or Metastatic Breast Cancer
UCCRC-NCI-6580, NCI-6580, UCCRC-13200A	A Randomized, Multicenter, Phase II Clinical Trial of Bevacizumab and Gemcitabine with Cetuximab Versus Erlotinib in Patients with Advanced Adenocarcinoma of the Pancreas
RPCI-PH-04603, ZENECA-IRUSIRES0303, RPCI-I-04603	A Phase I/II Clinical Trial of Oxaliplatin and Gefitinib in Combination with Radiotherapy in Patients with Locally Advanced or Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus or Gastroesophageal Junction
UCLA-0109030-03, TORI B-03, Western IRB #20041069, UCLA IRB #01-09-030	A Phase I/II Clinical Trial of Bevacizumab and Trastuzumab in Women with Relapsed or Metastatic Her2/Neu Overexpressing Adenocarcinoma of the Breast
IMCL-0452, CP02-0452	A Multicenter, Open-Label, Randomized, Phase III Clinical Trial of Docetaxel or Pemetrexed with or Without Cetuximab in Patients with Recurrent or Progressive Non-Small Cell Lung Cancer
CA225006, NCT00063141	A Randomized, Open-Label, Active Control, Parallel Assignment, Multicenter, Phase III Clinical Trial of Irinotecan and Cetuximab Compared to Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFr-Positive Colorectal Cancer
MSKCC-99085, CWRU-LILY-1599, LILLY-H3E-MC-JMCH(a), NCI-G00-1767	A Randomized, Multicenter Phase III Clinical Trial of Pemetrexed and Cisplatin Versus Cisplatin Alone In Chemonaive Patients with Malignant Pleural Mesothelioma
E-E4802, ECOG-E4802	A Multicenter Phase II Clinical Trial of Pemetrexed and Gemcitabine in Patients with Chemotherapy-Naive, Advanced Cancer of the Urothelium
CALGB-90206, CDR0000335292, CAN-NCIC-CLB-90206	A Two-Arm, Phase III Trial Of Bevacizumab in Combination with Interferon Alfa-2B in Patients with Advanced Renal Carcinoma
UCCRC-11046A, NCI-2710	A Phase II Clinical Trial of Gemcitabine and Cisplatin with or Without Bevacizumab in Patients with Malignant Mesothelioma
OSU-01H0185, NCI-2669	A Randomized, Multicenter, Phase II Clinical Trial of Bevacizumab with or Without Interferon Alfa in Patients with Metastatic Malignant Melanoma
CDR0000271225, MDA-ID-02063, NCI-4772	A Randomized, Phase II Trial of Bevacizumab and PEG-Interferon Alfa-2b in Patients with Metastatic or Unresectable Carcinoid Tumors
UPCC-03903, NCI-6006, CDR0000343804	A Dose-Escalation, Open-Label, Phase I/II Clinical Trial of Bevacizumab and Imatinib Mesylate in Patients with Advanced Melanoma or Other Advanced Cancers
NSABP-C-08	A Randomized Phase III Clinical Trial of Adjuvant Chemotherapy Consisting of Fluorouracil, Leucovorin Calcium, and Oxaliplatin with or Without Bevacizumab in Patients with Resected Stage II or III Adenocarcinoma of the Colon
MDA-2004-0342, NCI-6484	A Randomized Phase II Clinical Trial of Idarubicin and Cytarabine with or Without Bevacizumab in Patients with Newly Diagnosed Acute Myeloid Leukemia
04-033, MSKCC-04033	An Phase I/II Clinical Trial of Fixed Doses of Daily Gefitinib with Escalating Doses of Daily Everolimus In Advanced Non-Small Cell Lung Cancer
ECOG-E3303	A Multicenter, Phase II Clinical Trial of Cetuximab, Cisplatin, and Definitive Radiotherapy in Patients with Unresectable Locally Advanced or Regional Stage IV Squamous Cell or Undifferentiated Carcinoma of the Head and Neck
RTOG-0320	A Randomized, Multicenter, Phase III Clinical Trial of Whole Brain Radiotherapy and Stereotactic Radiosurgery with Versus Without Temozolomide or Gefitinib in Patients with Non-Small Cell Lung Cancer and Brain Metastases
UCHSC-01460, NCI-4551	A Multicenter, Dose-Escalation, Phase I Clinical Trial of Gefitinib in Combination with Radiotherapy with or Without Cisplatin in Patients with Previously Untreated, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
PBTC-007	A Multicenter, Dose-Escalation, Phase II Clinical Trial of Gefitinib in Combination with Radiation Therapy in Children with Newly Diagnosed Glioma
CA225081	A Non-Randomized, Open-Label, Uncontrolled, Phase II Clinical Trial of Carboplatin and Cetuximab in Previously Untreated Patients with Stage IIIb/IV Non-Small Cell Lung Cancer
CA225058	A Randomized, Open-Label, Dose-Comparison, Phase II Clinical Trial of Two Dose Schedules of Carboplatin, Paclitaxel, and Cetuximab in Previously Untreated Patients with Stage IIIb/IV Non-Small Cell Lung Cancer
PRA-OSI2950g, GENENTECH-OSI2950g, UCLA-0408116-01	A Randomized, Placebo-Controlled, Double-Blind (for Arms I and II), Phase II Clinical Trial of Bevacizumab with Either Docetaxel or Erlotinib Versus Docetaxel Alone in Patients with Recurrent or Refractory Stage IIIb or IV Non-Small Cell Lung Cancer
JHOC-20020723; NCI-5375, CDR0000257942	A Multicenter, Dose-Escalation, Phase I Clinical Trial of Erlotinib and Radiotherapy with or Without Cisplatin in Treating Stage II, III, or IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
ID02-327	A Phase II Clinical Trial of Erlotinib in Combination with Standard Chemotherapy (Carboplatin And Paclitaxel) Before Surgery in the Treatment of Non-Small Cell Lung Cancer.
COG-ADVL0214, CDR0000350336	A Phase I Clinical Trial of Erlotinib and Temozolomide in Children with Recurrent or Refractory Solid Tumors
UCDCC#128	A Phase I/II Clinical Trial of Docetaxel and Erlotinib in Patients with Advanced Solid Tumors with an Emphasis on Non-Small Cell Lung Cancer
040256, 04-C-0256	A Phase I Clinical Trial of Erlotinib Followed by Erlotinib with Temozolomide in Patients with Selected Recurrent/Refractory Solid Tumors
ECOG-E4203	A Randomized, Multicenter, Phase II Clinical Trial of Bevacizumab and Oxaliplatin Combined with Irinotecan Versus Leucovorin Calcium and Fluorouracil in Patients with Previously Untreated Metastatic or Locally Recurrent Colorectal Adenocarcinoma
03114	A Phase II Clinical Trial of Oxaliplatin, Capecitabine, and Bevacizumab in Patients with Metastatic Colorectal Cancer
ROCHE-BO16216, CWRU-030118, GENENTECH-H2223g, ROCHE-1100, ROCHE-B016216E, NCT00022672	A Randomized, Open-Label, Multicenter, Phase II/III Clinical Trial of Anastrozole with or Without Trastuzumab in Postmenopausal Women with Hormone-Receptor Positive, HER2-Overexpressing, Metastatic Breast Cancer
NCCTG-N0337, NCT00093808	A Multicenter Phase II Clinical Trial of Capecitabine, Vinorelbine and Trastuzumab as a First or Second-Line Treatment in Patients with HER2/Neu-Overexpressing Metastatic Breast Cancer
EORTC-10995, EORTC-16999, NCT00036868, IDBBC-EORTC-10995	A Phase II Clinical Trial of Cyclophosphamide, Methotrexate, Fluorouracil, and Trastuzumab in Women with HER2/Neu-Positive Metastatic Breast Cancer
FCCC-03041, NOVARTIS-FCCC-03041, NCT00084513	A Dose-Escalation, Phase I Clinical Trial of Trastuzumab and Imatinib Mesylate in Patients with Recurrent or Metastatic HER2/Neu-Overexpressing Cancer
UCLA-0407057-01, ZENECA-IRUSIRES0281	A Phase I/II Clinical Trial of Gefitinib and Sirolimus in Patients with Recurrent or Refractory Stage IIIb Or IV Non-Small Cell Lung Cancer
D7919C00706	A Randomized, Double-Blind, Placebo Controlled, Phase II Clinical Trial of Gefitinib in Patients with Previously Untreated Head and Neck Squamous Cell Carcinoma
CTRC-IDD-0332, NCI-6588	A Randomized, Phase I/II Clinical Trial of Erlotinib and Cetuximab with or Without Bevacizumab in Patients with Metastatic or Unresectable Renal Cell, Colorectal, Head and Neck, or Non-Small Cell Lung Cancer
RPCI-I-19903, GENENTECH-RPCI-I-19903	An Open-Label, Phase II Clinical Trial of Gemcitabine, Capecitabine, and Bevacizumab in Patients with Metastatic or Unresectable Adenocarcinoma of the Pancreas
NYWCCC-1004-528, NCI-6490	A Phase II Clinical Trial of Oxaliplatin, Fluourouracil, Leucovorin Calcium, Bevacizumab, and Cetuximab in Patients with Unresectable Stage IV Colorectal Cancer
GOG-0076DD, BMS-CA225-075	A Multicenter, Phase II Clinical Trial of Cetuximab and Cisplatin in Patients with Advanced, Persistent, or Recurrent Carcinoma of the Cervix
ECOG-E1B03	A Randomized, Multicenter, Phase II Clinical Trial of Pemetrexed Combined with Either Gemcitabine or Carboplatin in Patients with Advanced Malignant Mesothelioma of the Pleura
9439	A Phase I/II Clinical Trial of Gemcitabine and Cisplatin Followed by Pemetrexed and Gemcitabine in Patients with Advanced or Metastatic Bladder Cancer
NO17629, NCT00089479	A Phase III Clinical Trial of Doxorubicin With Cyclophosphamide Followed by Docetaxel Alone or With Capecitabine as Adjuvant Therapy in Female Patients With High-Risk Breast Cancer
DUMC03, NCT00090610	A Phase III Clinical Trial of Docetaxel and Carboplatin as a Second-Line Treatment in Patients With Platinum-Sensitive Ovarian Cancer
NSABP-B-38, NCT00093795	A Randomized, Multicenter, Phase III Clinical Trial of 3 Different Adjuvant Chemotherapy Regimens Including Docetaxel, Doxorubicin and Cyclophosphamide, or Dose-Dense Doxorubicin, Cyclophosphamide, and Paclitaxel, or Dose-Dense Doxorubicin, Cyclophosphamide, Paclitaxel and Gemcitabine in Women With Node-Positive Breast Cancer
DOXIL-BCA-3001, NCT00091442	A Randomized, Parallel-Group, Open-Label, Phase III Clinical Trial of Docetaxel Alone or in Combination With Doxorubicin in Patients With Recurrent, Advanced Breast Cancer Who Were Administered Anthracycline in the Adjuvant or Neoadjuvant Setting
DFCI-04006, AVENTIS-DFCI-04006, NCT00095875	A Randomized Phase III Clinical Trial of Induction Chemotherapy Comprising of Docetaxel, Cisplatin, and Fluorouracil Followed by Radiotherapy and Carboplatin or Docetaxel Versus Radiotherapy and Cisplatin Only in Patients With Previously Untreated Stage III or IV Squamous Cell Carcinoma of the Head and Neck
SWOG-S0016, NCT00006721, CALGB-50102	A Randomized Phase III Clinical Trial of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Combined With Either Rituximab or Tositumomab
SWOG-S0347, NCT00103233	A Randomized Phase III Clinical Trial of Vinorelbine With and Without Trastuzumab in Women With HEr2 Positive Progressive Metastatic Breast Cancer
8426	A Phase II Clinical Trial of Pemetrexed With Doxorubicin in Patients With Advanced Breast Cancer
EORTC-08013, EUDRACT-2004-001332-23, NCT00103051	An Open-Label, Nonrandomized, Multicenter, Phase II Clinical Trial of Neoadjuvant Induction Therapy Comprising of Gemcitabine, Cisplatin, and Gefitinib in Patients With Stage IIIa Non-Small Cell Lung Cancer Undergoing Surgery
MUSC-031218, MUSC-HR-11357, NCT00103376	A 2-Part, Open-Label, Phase II Clinical Trial of Bortezomib With or Without Combined Androgen Blockade Therapy in Patients With Early Relapsed Adenocarcinoma of the Prostate
SWOG-S0124, CTSU, NCT00045162, CALGB-S0124, NCCTG-S0124	A Randomized Phase III Clinical Trial of Cisplatin and Irinotecan Versus Cisplatin and Etoposide in Patients With Extensive Stage, Small Cell Lung Cancer
FFCD-EORTC-40012, EORTC-40012, PETACC-4, NCT00091312	A Randomized Phase III Clinical Trial of Fluorouracil and Irinotecan With or Without Leucovorin Calcium Compared to no Adjuvant Therapy in Patients With Resected, Stage II Adenocarcinoma of the Colon
NO16967, NCT00069108	A Phase III Clinical Trial of Capecitabine in Combination With Oxaliplatin (XELOX) Compared to Fluorouracil in Combination With Leucovorin and Oxaliplatin (FOLFOX4) in Patients With Metastatic Colorectal Cancer Who Have Previously Been Administered Irinotecan in Combination With Fluorouracil and Leucovorin
L_9210, NCT00087802	A Phase III Clinical Trial of Gemcitabine and Oxaliplatin Compared to Carboplatin and Paclitaxel in Patients With Advanced, Non-Small Cell Lung Cancer
GOG-9918	A Dose-Escalation, Multicenter, Phase I Clinical Trial of Cetuximab in Combination With Cisplatin, External Beam Radiotherapy and Brachytherapy in Patients With Stage Ib-IVa Cervical Cancer
A5961065	An Open Label, Non-Randomized, Phase IV Clinical Trial of Irinotecan in Combination With 5-FU, Leucovorin And Bevacizumab in Patients With Colorectal Carcinoma That Has Spread to the Liver Only and is Currently Not Able to be Removed by Surgery
RPCI-I-22204, GENENTECH-RPCI-I-22204	An Open Label Phase II Clinical Trial of Bevacizumab and Capecitabine as a First-Line Treatment in Older Patients With Metastatic Colorectal Cancer
TUGSM-UHA-BC03-01, NCT00107393	A Phase II Clinical Trial of Trastuzumab and Capecitabine in Patients With Taxane and Anthracycline-Refractory, HEr2/Neu Overexpressing, Metastatic Breast Cancer
CDR0000416124; FRE-FNCLCC-GETUG-13/0206; EU-20502; NCT00104676	A Randomized Phase III Clinical Trial of Bleomycin, Etoposide, and Cisplatin With or Without Dose-Dense Sequential Combination Chemotherapy (Paclitaxel, Oxaliplatin, And Ifosfamide) in Patients With Poor Prognosis Stage II or III Non-Seminomatous Germ Cell Tumors
COG-AOST0121	A Multicenter Phase II Clinical Trial of Trastuzumab And Chemotherapy in Patients With HEr2-Overexpressing Metastatic Osteosarcoma
SWS-SAKK-22/99; EU-99028	A Randomized Multicenter Phase III Trial of Trastuzumab With or Without Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HEr2
CLB-49903	A Randomized Phase III Clinical Trial of Trastuzumab With or Without Tamoxifen in Treating Women With Invasive Stage IV Breast Cancer.
NCCTG-N0531	A Multicenter Phase II Clinical Trial Of Nanoparticle Albumin-Bound Paclitaxel (Abraxane, ABI-007) And Gemcitabine In Women With Metastatic Breast Cancer
MSKCC-04018, ABI-CA016, NCT00085605, CA016-0	An Open Label, Phase II Clinical Trial of Nanoparticle Albumin-Bound Paclitaxel (Abraxane, ABI-007), Carboplatin and Trastuzumab in Patients With Her2/Neu-Overexpressing Metastatic Breast Cancer
CALGB-90401, NCT00110214	A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Clinical Trial of Docetaxel and Prednisone With Versus Without Bevacizumab in Patients With Hormone-Refractory Metastatic Adenocarcinoma of the Prostate
SWOG-S0414, NCT00109850	A Multicenter Phase II Clinical Trial of Cetuximab, Cisplatin, Irinotecan and Thoracic Radiotherapy in Patients With Previously Untreated, Clinically Inoperable, Locally Advanced Squamous Cell Carcinoma or Adenocarcinoma of the Esophagus
CA225-085	A Phase I Clinical Trial of Cetuximab in Combination With Irinotecan in Pediatric and Adolescent Patients With Refractory Solid Tumors
2003-1049	A Phase I Clinical Trial of Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy in Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
2003-0982	A Non-Randomized, Open Label Phase II Clinical Trial of Neoadjuvant Erlotinib and Bevacizumab In Patients With Metastatic, Clear Cell Renal Cell Carcinoma
UCLA-0412086-01, ROCHE-BO17920A	A Randomized, Open Label, Multicenter Phase III Clinical Trial of Adjuvant Oxaliplatin, Leucovorin Calcium and Fluorouracil (FOLFOX-4) Compared to Bevacizumab and FOLFOX-4 Compared to Bevacizumab, Oxaliplatin and Capecitabine in Patients With High-Risk Stage II or III Colon Cancer
NCCTG-N034A	A Multicenter Phase II Clinical Trial of Bevacizumab, Gemcitabine and Oxaliplatin in Patients With Metastatic Adenocarcinoma of the Pancreas
2003-0832	A Non Randomized, Open Label Phase II Clinical Trial of Neoadjuvant Concurrent Capecitabine, Bevacizumab and Radiotherapy in Patients Presenting With Locally Advanced Rectal Cancer
CA225-099	A Phase II Clinical Trial Of a Taxane and Carboplatin With or Without Cetuximab as a First-Line Treatment for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
CA225-100	A Phase II Clinical Trial of Gemcitabine and Platinum With or Without Cetuximab as a First-Line Treatment for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
MCC 13726	A Phase II Clinical Trial of Neoadjuvant Chemotherapy With Gemcitabine and Pemetrexed in Operable Non-Small Cell Lung Cancer
RTOG-0411, NCT00114179	A Phase II Clinical Trial of Capecitabine, Bevacizumab, and Radiotherapy Followed by Maintenance Therapy Comprising Gemcitabine and Bevacizumab in Patients With Inoperable Locally Advanced Pancreatic Cancer
NSABP FB-AX-003, NCT00110695	A Non Randomized Phase II Clinical Trial of Nanoparticle Albumin Bound Paclitaxel (ABI-007, Abraxane) in Combination With 5-Fluorouracil, Epirubicin and Cyclophosphamide in Women With Locally Advanced Breast Cancer
RTOG-0412, NCT00113386, SWOG-S0332	A Randomized, Multicenter Phase III Clinical Trial of Neoadjuvant Cisplatin and Docetaxel With Versus Without Thoracic Conformal Radiotherapy Followed by Surgical Resection and Docetaxel in Patients With Newly Diagnosed Favorable Prognosis Stage IIIa Non-Small Cell Lung Cancer
RTOG-0421, ECOG-R0421, NCT00113399	A Randomized Phase III Clinical Trial of Radiotherapy, Cisplatin and Paclitaxel Compared to Cisplatin-Based Chemotherapy Alone (With Fluorouracil, Paclitaxel, or Docetaxel) In Patients With Previously Irradiated, Inoperable, Locally Recurrent Squamous Cell Carcinoma of the Head And Neck
01-2003, MO17728	A Randomized, Open Label Phase III Clinical Trial of Docetaxel Followed by Cyclophosphamide, Epirubicin and 5-Fluorouracil (CEF) Compared to Docetaxel and Capecitabine Followed by Cyclophosphamide, Epirubicin and Capecitabine (CEX) as Adjuvant Treatment for Early Breast Cancer With an Intermediate-To-High Risk of Cancer Recurrence
FRE-FNCLCC-ACCORD-11/0402, EU-20512, NCT00112658	A Randomized Phase II/III Clinical Trial of Oxaliplatin, Irinotecan, Leucovorin Calcium and 5-Fluorouracil Compared to Gemcitabine as a First-Line Therapy in Patients With Metastatic Adenocarcinoma of the Pancreas
CASE-2204, CWRU-100450, OSI-CASE-2204	A Phase I Clinical Trial of Erlotinib Followed by Oxaliplatin, Leucovorin Calcium and Fluorouracil (Modified FOLFOX6) as First-Line Therapy in Patients With Metastatic Colorectal Cancer
04-365	A Non-Randomized, Open Label Phase II Clinical Trial of Bevacizumab and Erlotinib in Combination With Fluorouracil, Leucovorin and Oxaliplatin (FOLFOX) in Patients With Previously Untreated, Metastatic Colorectal Cancer
CALGB-30306	A Phase II Clinical Trial of Cisplatin, Irinotecan and Bevacizumab in Patients With Extensive Stage Small Cell Lung Cancer
SWOG-S0408, ECOG-SWOG-S0408	A Multicenter Phase II Clinical Trial of Neoadjuvant Capecitabine, Oxaliplatin, and Bevacizumab in Patients With Operable Hepatic Metastases Secondary to Colorectal Cancer
ECOG-E2104	A Multicenter Phase II Clinical Trial of Adjuvant Bevacizumab and Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Patients With Resected Lymph Node-Positive Breast Cancer
CALGB-30402	A Randomized, Multicenter Phase II Clinical Trial of Docetaxel in Combination With Either Cetuximab or Bortezomib as a First-Line Therapy in Patients With Stage IIIb or IV, Performance Status 2 Non-Small Cell Lung Cancer
CALGB-30407	A Randomized, Multicenter Phase II Clinical Trial of Pemetrexed Disodium, Carboplatin, and Thoracic Radiotherapy With or Without Cetuximab in Patients With Inoperable, Stage III Non-Small Cell Lung Cancer
NEAR L-284/2004	A Non-Randomized, Open Label Phase II Clinical Trial of Cetuximab in Combination With Locoregional Radiotherapy in Patients With Inoperable, Stage III Non-Small Cell Lung Cancer
IRB 6320	A Phase II Clinical Trial of Erlotinib With Temozolomide and Concurrent Radiation Therapy in Patients With Newly-Diagnosed Glioblastoma Multiforme
	A Phase II Clinical Trial of Erlotinib in Combination With Capecitabine in Patients With Advanced, Metastatic Pancreatic Cancer Who Failed First-Line Gemcitabine-Based Therapy
UNKPRI 15	A Phase II Clinical Trial of Bevacizumab and Erlotinib in Patients With Metastatic Carcinoma of Unknown Primary Site
	A Randomized Phase III Trial of Adjuvant Chemotherapy With Cisplatin and Vindesine Followed by UFT for Completely Resected Pathologic Stage IIIa-N2 Non-Small Cell Lung Cancer (NSCLC)-West Japan Study Group for Lung Cancer Surgery (WJSG)
	Phase I/II Study of Weekly Paclitaxel, UFT and Leucovorin in Patients with Metastatic Breast Cancer
	A Phase II Trial of Adjuvant Chemotherapy with Weekly Paclitaxel and Carboplatin Followed by UFT for Completely Resected Pathologic Stage II and IIIA Non-Small Cell Lung Cancer (NSCLC)
	A Multicenter, Phase II Clinical Trial of Oxaliplatin, Uracil/Tegafur and Radiotherapy in Patients with Operable Rectal Cancer
ECOG 1299	A Phase II Study of Orzel (UFT+Leucovorin) in Elderly Patients with Colorectal Cancer
SWOG-S0515	A Phase II Clinical Trial of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab in Combination With Bevacizumab in Older Patients With Bulky Stage II or Stage III or IV Diffuse Large B-Cell Lymphoma
	A Phase I Trial of Low Dose Cisplatin, UFT, Diethylstilbestrol, and Dexamethasone (CUDD) for Patients with HRPC
GOC-GI-010	A Non-Randomized, Uncontrolled Phase II Clinical Trial of Oxaliplatin, Capecitabine and Bevacizumab in Older Patients with Colorectal Cancer
	A Multicenter Phase II Study of Adjuvant Bi-Weekly Irinotecan , Infusional 5-Fluorouracil (5FU) and Leucovorin (LV) with Oral Tegafur/Uracil (UFT) Following Resection of Colorectal Hepatic Metastases
05-055, NCT00121134	A Non-Randomized, Open Label Phase II Clinical Trial of Bevacizumab With or Without Cyclophosphamide and Methotrexate in Women With Operable Breast Cancer
ML18527	A Phase IV Clinical Trial of Cepecitabine and Bevacizumab in Previously Untreated Patients With HEr2-Negative, Metastatic Breast Cancer Followed by Chemotherapy (Paclitaxel or Vinorelbine) Combined With Bevacizumab if Disease Progresses
ML18491	A Phase IV Clinical Trial of 2 Different Treatment Schedule of Intermittent Capecitabine and Oxaliplatin Combined With Bevacizumab as First-Line Treatment in Patients With Metastatic Colorectal Cancer
	An Open, Multi Center, Phase II Clinical Trial to Evaluate Efficacy and Safety of Paclitaxel, UFT, and Leucovorin in Patients with Advanced Gastric Cancer
	A Multicenter Phase II Trial of Pre-Administrated UFT Plus Gemcitabine for Unresectable/Recurrent Pancreatic Cancer
	UFT After Sequential Chemo and Radiotherapy in Patients with Stage IIIb Non-Small Cell Lung Cancer
CINJ-040412, CINJ-5191, CINJ-NJ1104, NCT00118053	A Non Randomized, Multicenter Phase II Clinical Trial of Trastuzumab, Docetaxel and Carboplatin in Women With Previously Untreated, HEr2/Neu-Positive, Stage IIb, IIIa, IIIb Or IIIc, or Inflammatory Breast Cancer
	A Randomized Controlled Study Comparing cyclophosphamide, methotrexate, and 5-Fluorouracil Plus Tamoxifen with UFT Plus Tamoxifen as Postoperative Adjuvant Therapy in Women with Node-Positive Breast Cancer
	A Phase III Trial of Adjuvant Chemotherapy with UFT for Serosa Negative Advanced Gastric Cancer
EMR 62202-002	A Randomized, Open Label Phase III Clinical Trial of Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil Compared to Cetuximab Alone in The First Line Treatment of Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
	PhaseI/II Study of Paclitaxel, Carboplatin and UFT in Chemo-Naive Patients with Advanced Non-Small Lung Cancer
	Randomized Controlled Trial of Gemcitabine in Combination with UFT Versus Gemcitabine Alone in Patients with Advanced Pancreatic Cancer
	A Combination of Oxaliplatin and UFT-L,-Leucovorin as First Line Treatment in Advanced Colorectal Cancer-an Oncopaz Phase II Study.
	Adjuvant Oral UFT Improves Survival After Complete Mesorectal Excision or Pathologic Tumor, Nodes, Metastases Stage III Rectal Cancer
	A Phase I Trial of UFT And Oral Leucovorin + Weekly Oxaliplatin and Preoperative Radiotherapy In Locally Advanced Rectal Cancer
NSABP Protocol C-06	A Phase III Trial Comparing Oral UFT with Leucovorin to 5-FU with Leucovorin (FULV) in Stage II and III Carcinoma of the Colon
CALGB-50303, ECOG-50303, NCT00118209	A Randomized Phase III Clinical Trial of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Compared to Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, and Rituximab (EPOCH-R) in Patients With Previously Untreated, De Novo, Diffuse, Large B-Cell Non-Hodgkin’s Lymphoma
BMTCTN-0202, FMLH-04-143, HRRC-301-04, NCT00096460	A Phase II/III Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation (HSCT) or Non-Myeloablative Allogeic HSCT from a HLA-Matched Sibling Donor in Patients with Recurrent Grade I or II Follicular Non-Hodgkin’s Lymphoma
SWOG-S9704, NCT00004031, CALGB-59903, CAN-NCIC-LY11, ECOG-S9704	A Randomized Phase III Clinical Trial of Early High-Dose Chemoradiotherapy and Autologous Peripheral Blood Stem Cell Transplantation Compared to Conventional Dose Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Patients with Intermediate- or High-Grade Non-Hodgkin's Lymphoma
MSKCC-03139, CORAL-50-03B, NCT00081146	A Randomized, Open Label, Multicenter Phase III Clinical Trial of Rituximab, Ifosfamide, Carboplatin, and Etoposide Compared to Rituximab, Dexamethasone, Cytarabine, and Cisplatin as Induction Therapy Followed by High-Dose Consolidation Chemotherapy and Autologous Stem Cell Transplantation With Versus Without Rituximab as Maintenance Therapy in Patients With Relapsed or Refractory CD20-Positive Diffuse Large B-Cell Non-Hodgkin's Lymphoma
	A Dose Finding Phase I Trial Followed By a Phase II Trial of Oral UFT and Leucovorin Plus IV Mitomycin in Patients with Metastatic Colorectal Cancer
IRB 13362B	A Randomized, Open Label, Phase III Clinical Trial of Induction Therapy with Docetaxel Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone in Patients with Locally Advanced, Head and Neck Cancer
05-043	A Randomized, Open Label Phase III Clinical Trial of Androgen Suppression and Radiation Therapy for 6 Months With or Without Docetaxel in Men With High Risk Localized or Locally Advanced Prostate Cancer
NO16853	A Phase III Clinical Trial of Capecitabine With or Without Docetaxel in Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Chemotherapy With Anthracycline
	A Phase I Clinical Trial of Gefitinib, Oxaliplatin, 5-Fluorouracil and Leucovorin in Patients With Advanced Solid Malignancies
	A Multicenter Phase II Trial of BiWeekly Irinotecan, Infusional 5-Fluorouracil and Leucovorin with Oral UFT for Metastatic Colorectal Cancer
	A Phase I/II Study of Tegafur-Uracil (UFT) Plus Oral Leucovorin and Biweekly Irinotecan Therapy For Patients with Metastatic Colorectal Cancer
EORTC-40986	A Phase III Clinical Trial of Weekly High-Dose Infusional Fluourouracil and Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer
	A Phase II Trial of High Dose Radiotherapy and UFT/Leucovorin in Patients with Locally Advanced Rectal Cancer
	Docetaxel, Cisplatin, UFT and Leucovorin Combination Chemotherapy in Advanced Gastric Cancer
	Oxaliplatin, UFT and Oral Leucovorin Combination Chemotherapy in Patients with 5-Fluorouracil Refractory Colorectal Carcinoma
	Pilot Trial of Irinotecan and Thalidomide in Patients with Advanced Cancer
	A Randomized Phase III Clinical Trial of the Irinotecan, Leucovorin, And Fluorouracil Regimen (FOLFIRI) Compared to the Oxaliplatin, Leucovorin, and Fluorouracil Regimen (FOLFOX4) in Previously Untreated Patients With Advanced Colorectal Cancer
	Phase II Study of a Fixed Dose Rate Infusion of Gemcitabine Associated to Cisplatin and UFT in Advanced Carcinoma of the Pancreas
	Phase II Study of Vinorelbine and UFT in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes
	Preoperative Radiation and Daily Oral UFT in Combination with Leucovorin In Locally Advanced Rectal Cancer
	Combination Study of UFT with Leucovorin and Oxaliplatin as First Line Treatment for Patients with Nonresectable Metastatic Colorectal Cancer
	A Phase II Trial of Oxaliplatin and UFT with Folinic Acid for Advanced Colorectal Cancer in Elderly Patients